©2018 Shenzhen Foncoo Pharmaceutical Co., Ltd.,Legal notices | Copyright Notice  | Contact us | links
粤ICP备13052717号-1 | 粤-非经营性-2018-0343



Tranexamic Acid Injection

Contact us

  • Shenzhen Foncoo Pharmaceutical Co., Ltd.
  • Tel:+86-0755-82873500
  • Fax:+86-0755-82873511
  • Hotline:+86-0755-82873505
  • Add:Unit 701,Block A,Guoren Building,Keji Middle 3rd Road,Hi-Tech Park,Nanshan District,Shenzhen,China.

Tranexamic Acid Injection

Product description

Product Name:Tranexamic Acid Injection

Manufacturer:Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd

Generic Name:Tranexamic Acid Injection

Approval Number:CFDA H20030587

Valid Period:24 Months



1. This product is mainly used for various types of bleeding caused by acute or chronic, localized or systemic primary fibrinolysis. The secondary hyperfibrinolysis state caused by disseminated intravascular coagulation is generally not used before heparinization.
2. It is used for trauma or surgical bleeding of plasminogen activator organs such as prostate, urethra, lung, brain, uterus, adrenal gland and thyroid.
3. Used as an antagonist of tissue plasminogen activator (t-PA), streptokinase and urokinase.
4. It is used for artificial abortion, early exfoliation of placenta, fibrinolytic hemorrhage caused by stillbirth and amniotic fluid embolism, and menstrual hyperplasia of pathological intrauterine local fibrinolysis.
5. For the treatment of mild hemorrhage of central nervous system, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage, the use of this product to stop bleeding is better than other anti-fibrosis.

Corresponding parameter set not found, please add it in property template of background